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Abstract. 
 
Gelsolin and CapG are actin regulatory pro-
teins that remodel the cytoskeleton in response to 
 
phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
) and Ca
 
2
 
1
 
 
during agonist stimulation. A physiologically relevant 
rise in Ca
 
2
 
1
 
 increases their affinity for PIP
 
2
 
 and can 
promote significant interactions with PIP
 
2
 
 in activated 
cells. This may impact divergent PIP
 
2
 
- dependent sig-
naling processes at the level of substrate availability. 
We found that CapG overexpression enhances PDGF-
stimulated phospholipase C
 
g
 
 (PLC
 
g
 
) activity (Sun, H.-q., 
K. Kwiatkowska, D.C. Wooten, and H.L. Yin. 1995. 
 
J. 
Cell Biol.
 
 129:147–156). In this paper, we examined the 
ability of gelsolin and CapG to compete with another 
PLC for PIP
 
2
 
 in live cells, in semiintact cells, and in 
vitro. We found that CapG and gelsolin overexpression 
profoundly inhibited bradykinin-stimulated PLC
 
b
 
. In-
hibition occurred at or after the G protein activation 
step because overexpression also reduced the response 
to direct G protein activation with NaF. Bradykinin re-
sponsiveness was restored after cytosolic proteins, in-
cluding gelsolin, leaked out of the overexpressing cells. 
Conversely, exogenous gelsolin added to permeabilized 
cells inhibited response in a dose-dependent manner. 
The washout and addback experiments clearly establish 
that excess gelsolin is the primary cause of PLC inhibi-
tion in cells. In vitro experiments showed that gelsolin 
and CapG stimulated as well as inhibited PLC
 
b
 
, and 
only gelsolin domains containing PIP
 
2
 
-binding sites 
were effective. Inhibition was mitigated by increasing 
PIP
 
2
 
 concentration in a manner consistent with compe-
tition between gelsolin and PLC
 
b
 
 for PIP
 
2
 
. Gelsolin and 
CapG also had biphasic effects on tyrosine kinase–
phosphorylated PLC
 
g
 
, although they inhibited PLC
 
g
 
 
less than PLC
 
b
 
. Our findings indicate that as PIP
 
2
 
 level 
and availability change during signaling, cross talk be-
tween PIP
 
2
 
-regulated proteins provides a selective 
mechanism for positive as well as negative regulation of 
the signal transduction cascade.
 
G
 
elsolin 
 
(33) and CapG (36) are members of an ac-
tin filament severing and capping protein family.
They are activated by
 
 C
 
a
 
2
 
1
 
 and inhibited by poly-
phosphoinositides, particularly phosphatidylinositol 4,5-
bisphosphate (PIP
 
2
 
)
 
1
 
 (15, 33, 36). It is postulated that ago-
nist-induced changes in Ca
 
2
 
1
 
 and plasma membrane PIP
 
2
 
levels alter the partitioning of gelsolin between the plasma
membrane, cytosol, and actin filament ends (2, 3, 7, 8, 12,
19). These changes initiate actin filament severing and cap-
ping to remodel the cytoskeleton (14).
There is also emerging evidence to suggest that actin
regulatory protein binding to PIP
 
2
 
 may have implications
beyond a direct effect on the cytoskeleton. In vitro, gelso-
lin modulates the activity of several important signaling
enzymes through an effect on their interactions with PIP
 
2
 
.
It alters the activity of phosphoinositide-specific phospho-
lipase C (PLC) (1), phospholipase D (30), and phospho-
inositide 3-OH kinase (30; Lu, P., A. Hsu, D. Wong, H.
Yun, H.L. Yin, and C. Chen, manuscript submitted for
publication). Therefore, gelsolin and CapG may be com-
ponents of a signaling complex that transduces external
stimuli to the cytoskeleton. The possibility of cross talk be-
tween divergent PIP
 
2
 
-binding proteins through regulation
of substrate availability is particularly relevant as more
PIP
 
2
 
-binding proteins are identified. Many pleckstrin ho-
mology domain proteins with important signaling func-
tions (27) bind PIP
 
2
 
 with affinity comparable to that of the
gelsolin family (18). We recently demonstrated that gelso-
lin and CapG affinity for PIP
 
2
 
 is increased six- to eightfold
by micromolar amounts of Ca
 
2
 
1
 
 (18). They can therefore
compete effectively for PIP
 
2
 
, particularly when cytosolic
[Ca
 
2
 
1
 
] increases and PIP
 
2
 
 level drops in agonist-stimulated
cells. We reported that NIH3T3 clones expressing slightly
more CapG than control clones have increased PDGF-
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1.
 
 Abbreviations used in this paper
 
: C, gelsolin-overexpressing lines; ctrl,
control clones; IP
 
3
 
, inositol 1,4,5-trisphosphate; PIP
 
2
 
, phosphatidylinositol
4,5-bisphosphate; PLC, phospholipase C; SLO, streptolysin O.
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stimulated PLC
 
g
 
 activity (31), supporting this possibility.
However, we did not anticipate a stimulatory effect since
previous in vitro studies indicate that gelsolin and profilin,
another PIP
 
2
 
-regulated actin-binding protein, inhibit PLC
 
g
 
(1, 10).
In this paper, we use a variety of approaches to deter-
mine how overexpression affects another PLC, PLC
 
b
 
, and
the basis for interaction in vivo. We also compared the ef-
fects of CapG and gelsolin overexpression. Gelsolin and
CapG are present in similar concentration (
 
z
 
0.7 
 
m
 
M) in
NIH3T3 cells (9, 31). The gelsolin clones have a wider range
of overexpression (9), and much more is known about
gelsolin PIP
 
2
 
-binding sites (16, 34, 37). They have the same
motility phenotype as CapG-overexpressing cells (9, 31),
but their phosphoinositide metabolism has not been exam-
ined.
 
Materials and Methods
 
Cell Lines
 
NIH3T3 cell lines stably overexpressing human gelsolin were gifts of Drs.
D.J. Kwiatkowski and C. Cunningham (Brigham and Women’s Hospital,
Boston, MA). They were obtained by transfection of a human cytoplasmic
gelsolin expression vector and clonally selected with neomycin (9). Early
passage cells that had been directly quantitated for gelsolin content were
used, and their gelsolin expression was reconfirmed in our laboratory (see
below). CapG overexpression cells were obtained as described in refer-
ence 31. Control (Ctrl) cells were transfected with the vector without a
cDNA insert. Cells were maintained in DME with 10% FCS.
For inositol 1,4,5-trisphosphate (IP
 
3
 
) and intracellular Ca
 
2
 
1
 
 measure-
ments, cell monolayers were starved in DME/0.2% serum for 24 h. They
were switched to a completely defined 1:1 DME/F12 medium supple-
mented with 20 mM Hepes, pH 7.4, 0.5 mg/ml BSA, 1 
 
m
 
g/ml insulin, and 1
 
m
 
g/ml transferrin (Q-medium) for an additional 18 h before agonist appli-
cation. In some cases, cells were treated with 100 ng/ml pertussis toxin
(List Biological Lab., Inc., Campbell, CA) overnight. Bradykinin and
PDGF (AB chains) were from Sigma Chemical Co. (St. Louis, MO) and
Upstate Biotechnology, Inc. (Lake Placid, NY), respectively.
 
Streptolysin O Permeabilization
 
Cells were trypsinized and resuspended in Chelex 100–treated buffer con-
taining 100 mM KCl, 20 mM NaCl, 20 mM Hepes, pH 7.4. 5 
 
3
 
 10
 
6
 
 cells
were permeabilized in 0.4–0.6 U/ml streptolysin O (SLO) (Murex Diag-
nostics Limited, Dartford, England) with 1 mg/ml creatinine phosphate,
0.1 mg/ml creatinine phosphokinase, 5 mM MgCl
 
2
 
, and 3 mM ATP (21).
Cells were usually permeabilized for 4 min at 37
 
8
 
C before agonist applica-
tion.
 
Gelsolin PIP
 
2
 
-binding Domains
 
Gelsolin NH
 
2
 
-terminal half domains containing zero to three PIP
 
2
 
-binding
sites were expressed in 
 
Escherichia coli
 
 and isolated as described (35, 37).
The final products were 
 
.
 
99% pure, based on Coomassie blue staining of
protein bands in sodium dodecyl sulfate polyacrylamide gels. Protein con-
centrations were determined by the method of Bradford (5). P2, a 22-mer
synthetic peptide encompassing gelsolin residues 150–169 (CKHVVP-
NEVVVQRLFQVKGRR, amino-terminal cysteine added) (16), was syn-
thesized by solid phase methods. CapG and thymosin 
 
b
 
4 were expressed
in 
 
E. coli
 
 and purified as described previously (35, 38).
 
Ca
 
2
 
1
 
 Measurements
 
Serum-deprived cells were washed and incubated with a buffer containing
Fura 2 (2.5 
 
m
 
M), 1 mg/ml BSA, and 2 mg/ml glucose for 1 h at room tem-
perature (31). Cells were trypsinized briefly and resuspended in a buffer
containing BSA and glucose and warmed to 37
 
8
 
C. Fluorescence measure-
ments were performed with 2 
 
3
 
 10
 
6
 
 cells in 1.5 ml with slow stirring at
37
 
8
 
C, at excitation and emission wavelengths of 340 and 500 nm, respec-
tively. [Ca
 
2
 
1
 
] was calibrated by adding 25 
 
m
 
g/ml digitonin and 0.25 mM
 
MnCl
 
2
 
 to obtain F
 
max
 
 and F
 
min
 
, respectively. A K
 
d
 
Ca
 
2
 
1
 
 of 224 nM was used
for calculation.
 
IP
 
3
 
 Content
 
Cell monolayers starved in Q-medium were stimulated with 5 
 
m
 
M brady-
kinin for 7 or 15 s, and the reaction was stopped by adding an equal vol-
ume of a 5% perchloric acid solution containing 10 mM EDTA and 1 
 
m
 
M
ATP. The soluble extract was neutralized with 1:1 freon/octylamine, and
IP
 
3
 
 content was assayed by competition with exogenous [
 
3
 
H]IP
 
3
 
 to bind
calf cerebellum microsomes (31). IP
 
3
 
 standards were extracted and as-
sayed under identical conditions. The IP
 
3
 
 content of permeabilized cells
was determined with cells in suspension under conditions identical to
those used for Ca
 
2
 
1
 
 measurements.
 
Immunoblotting
 
Cells were lysed in cold RIPA buffer containing a protease inhibitor cock-
tail as described previously (31). Lysate protein concentrations were de-
termined by the micro-BCA method (Pierce Chemical Co., Rockford, IL).
Proteins were electrophoresed on 5–10% polyacrylamide, discontinuous
pH slab gels in the presence of SDS and transferred to nitrocellulose for
Western blotting. Blots were probed with rabbit anti–mouse gelsolin,
which recognizes the endogenous gelsolin (31), and/or a monoclonal anti–
human gelsolin (clone 2C4), which recognizes human but not mouse
gelsolin (6). Endogenous mouse and overexpressed human gelsolin were
quantitated by comparing the intensity of gelsolin bands in cell lysates
with that of purified mouse and human plasma gelsolins, respectively, as
described in reference 9. In leak-out experiments, ctrl cells were perme-
abilized with streptolysin 
 
O
 
 at 37
 
8
 
C and centrifuged at 1,500 rpm in an Ep-
pendorf microcentrifuge for 1 min at room temperature. Samples were
blotted with rabbit anti–mouse gelsolin, rabbit anti-PLC
 
b
 
3
 
 (gift of P.
Sternweis, University of Texas Southwestern Medical Center, Dallas, TX)
(11), and monoclonal antiactin (clone C4; Boehringer Mannheim Corp.,
Indianapolis, IN).
 
PLC Assays
 
Recombinant PLC
 
b
 
1
 
 expressed in SF9 cells and purified to homogeneity
was a gift of Dr. E. Ross (University of Texas Southwestern Medical Cen-
ter) (4). Vesicles containing 100 
 
m
 
M phosphatidylethanolamine, 10 
 
m
 
M
phosphatidylserine, 10 
 
m
 
M PIP
 
2
 
, and 0.028 
 
m
 
M [
 
3
 
H] PIP
 
2
 
 were made by
sonicating in the PLC buffer (25 mM Hepes, 80 mM KCl, 3 mM EGTA,
0.5 mM DTT, pH 7.0). Vesicles were preincubated with gelsolin domains
in the presence of 11 
 
m
 
M free [Ca
 
2
 
1
 
] at 4
 
8
 
C for 10 min, and enzyme reac-
tion was initiated by adding 4 ng (per 60 
 
m
 
l) PLC
 
b
 
1
 
 and warming to 37
 
8
 
C.
Reactions were terminated after 1–4 min by adding TCA and 3 mg/ml
BSA. Precipitated proteins were removed by centrifugation, and radioac-
tive IP
 
3
 
 in the TCA-soluble supernatant was determined by scintillation
counting. Triplicate samples were assayed per condition. PIP
 
2
 
 hydrolysis
was linear for 15 min under the conditions used. In some experiments,
PIP
 
2
 
, ranging from 5–200 
 
m
 
M, was presented as micelles.
Phospholipase C
 
g
 
1
 
, purified from bovine brain (26), was a gift of Dr.
S.G. Rhee (National Institute of Health, Bethesda, MD). A preparation
enriched in EGF receptor tyrosine kinase was prepared from A431
plasma membrane by Triton X-100 extraction and passaged through a
wheat germ agglutinin column with 
 
N
 
-acetyl-
 
d
 
 glucosamine (32). The
eluted receptor preparation was dialyzed and used at 3 
 
m
 
g/ml to phosphor-
ylate 0.6 
 
m
 
g/ml PLC
 
g
 
1
 
 , in the presence of 20 
 
m
 
M ATP and 3 
 
m
 
M EGF at
4
 
8
 
C for 1 h (22). Its activity was assessed by incubating PLC
 
g
 
1
 
 with
[
 
32
 
P]ATP to detect EGF- dependent 
 
32
 
P incorporation. PLC
 
g
 
1
 
 activity was
assayed by using 6–12.5 ng PLC
 
g
 
1
 
/60 
 
m
 
l reaction mixture, and with vesicles
containing 10 
 
m
 
M PIP
 
2
 
/0.02 
 
m
 
M [
 
3
 
H]PIP2/100 mM PE. The buffer condi-
tions were as described above. The reaction was linear for at least 15 min
at 378C. Unphosphorylated PLCg1 control was incubated with the kinase
preparation in the absence of ATP and EGF.
Results
Ca21 Signaling in CapG Overexpressing Cells
We showed previously that CapG overexpression in-
creased Ca21 and IP3 response to PDGF (31). These re-
sults suggest that CapG enhanced PLCg in vivo, althoughSun et al. Gelsolin, CapG, PIP2, Phospholipase C 813
gelsolin (1) and CapG (see below) are predominantly in-
hibitory in vitro. We therefore examined the effect of
overexpression on PLCb, which is activated through the
bradykinin/heterotrimeric G protein pathway. 5 mM
bradykinin stimulated ctrl cells to increase cytosolic Ca21
in a sharp peak (Fig. 1 A). CapG clones had a reduced
Ca21 response (Fig. 1 A and Table I). Likewise, the IP3 re-
sponse was also attenuated. Bradykinin-stimulated ctrl
cells generated IP3 to a maximal level at 7 s (Fig. 1 B). The
CapG clones generated less IP3 at 7 and 15 s. Ca21 signal
and IP3 response were inhibited to a similar extent, sug-
gesting that CapG inhibited PLCb and Ca21 signaling by a
similar mechanism (see Fig. 3 B).
To explore the basis for the opposite effects of CapG
overexpression on PDGF- vs. bradykinin-activated PLC,
we felt that studying cells with a wider range of overex-
pression and comparing cells overexpressing related pro-
teins would be important. In spite of repeated attempts,
we were not able to isolate stable CapG clones with higher
overexpression. We therefore directed our effort to gelso-
lin-overexpressing clones, which have a wider range of
overexpression (9).
Effects of Gelsolin Overexpression on PIP2 Hydrolysis
Western blotting with human gelsolin–specific antibody,
which recognizes the transfected human gelsolin but not
endogenous mouse gelsolin, confirmed that the clones had
a range of gelsolin overexpression (Fig. 2, bottom), as de-
scribed previously (9). C2 was not positive, indicating that
it had lost the expression vector, and was not studied fur-
ther. Blotting with anti–mouse gelsolin, which cross-reacts
poorly with human gelsolin, showed that the endogenous
gelsolin level in overexpressing cells was comparable to
that of the ctrl cells (Fig. 2, top). Therefore, there was no
compensatory change in endogenous gelsolin expression.
Total gelsolin level, determined by quantitative Western
blotting using purified human and mouse gelsolin stan-
dards, confirmed that the levels of expression were similar
to that shown previously (9) (Table I).
Gelsolin overexpression modified the Ca21 response to
bradykinin. C3 that has 1.3 times as much gelsolin as ctrl
was slightly more responsive to bradykinin and PDGF
(Table I). In contrast, C6, C1, C4, and C5 that have higher
overexpression had a striking decrease in bradykinin-
induced Ca21 signal (Fig. 3, Table I). The PDGF response
was also reduced, but to a lesser extent (Table I). Since in-
hibition was observed with multiple independently iso-
lated clones, the phenotype was attributed to gelsolin
overexpression and was not an artifact of clonal selection.
The stimulation we observed with the lowest overexpress-
ing clone, C3, suggests that gelsolin may also increase sig-
naling. However, because only one such clone was avail-
able, ruling out clonal variations unrelated to gelsolin was
not possible.
Figure 1. Effect of CapG
overexpression on response
to bradykinin. Serum-
deprived fibroblasts were
stimulated with 5 mM brady-
kinin. (A) Ca21 tracings from
a representative experiment
were shown. Fura 2 was used
as an indicator. Top, ctrl; bot-
tom, gk15. Arrows indicate
time of bradykinin addition.
(B) IP3 generation as a func-
tion of time after stimulation.
Cells were extracted with
PCA, and IP3 level was de-
termined by a receptor bind-
ing assay. Results shown
were from a single represen-
tative experiment performed
in triplicate. Values were
mean  6 SEM.
Table I. Effects of Overexpression on Ca21 Signals
Clone
Fold
overexpression*
Ca21 (nM)‡
PDGF Bradykinin
Cap G ctrl 1 232 6 30 659 6 95
gK6 1.3 — 259 6 58
gK8 1.4 323 6 14 196 6 21
gK15 1.5 339 6 40 151 6 57
Gelsolin Ctrl 1 289 6 38 790 6 146
C3 1.3 352 6 20 1358 6 251
C6 1.4 179 6 25 270 6 60
C1 1.7 125 6 38 80 6 18
C4 2.1 104 6 10 30 6 5
C5 2.4 125 6 15 20 6 2
*Gelsolin content was determined by scanning of Western blots, using mouse and hu-
man gelsolin as standards to quantitate overexpressed and endogenous gelsolins, re-
spectively. Values were the means of three determinations. Cap G content was deter-
mined as described in reference 31.
‡Peak Ca21 concentration after stimulation with 50 ng/ml PDGF or 5 mM bradykinin.
Values were the means 6 SEM of three to five determinations.The Journal of Cell Biology, Volume 138, 1997 814
The effect of gelsolin on PLCb activity per se was con-
firmed by quantitating IP3. Ctrl and overexpressing clones
had similar basal IP3 levels (z10 pmol/mg cell protein).
Gelsolin clones had reduced IP3 response (Fig. 3 B), and
the extent of inhibition correlated with that of the Ca21 re-
sponse. Overall, our results are consistent with the hypoth-
esis that the gelsolin- and CapG-induced change in Ca21
signal was due to PLCb inhibition. 
Characterization of the Gelsolin Effect on the 
Bradykinin Response
Since the bradykinin response was strikingly inhibited, we
will focus on this aspect in the rest of the paper. Bradyki-
nin stimulation of Ca21 release is a multistep process that
involves bradykinin binding to receptors, activation of het-
erotrimeric G proteins, PLCb hydrolysis of PIP2, and IP3-
induced release of Ca21 from intracellular stores. Ctrl cells
responded to as low as 0.1 mM bradykinin, and Ca21 re-
lease was maximally stimulated at 1 mM (data not shown).
C5 had a very small Ca21 peak, even at 50 mM bradykinin,
suggesting that the problem was unlikely to be due to de-
creased receptor affinity. To identify the step compro-
mised by gelsolin overexpression, NaF was used to acti-
vate G proteins directly, bypassing receptor involvement.
NaF induced a slow Ca21 rise (Fig. 3 A), which had a smaller
amplitude than the bradykinin peak (320 6 50 nM).
Figure 2. Western blotting of gelsolin-overexpressing clones.
(Top) Anti–mouse gelsolin (anti-mG), detecting endogenous
gelsolin. (Bottom) Anti–human gelsolin (anti-hG), detecting the
expression of human gelsolin in human gelsolin cDNA–trans-
fected cells. ctrl, control-transfected NIH3T3 cells; C, gelsolin
overexpressing clones.
Figure 3. Effect of gelsolin and
CapG overexpression. (A) Ca21
tracings. Cells were stimulated
with 5 mM bradykinin or 20 mM
NaF. Tracings were from a rep-
resentative experiment. Arrows
indicate time of agonist addi-
tion.  Ctrl, mock-transfected
cells;  C1, gelsolin-overexpress-
ing cells. (B) Comparing the ef-
fects of gelsolin and CapG over-
expression. Cells were stimulated
with 5 mM bradykinin or 20 mM
NaF. Ca21 spike and IP3 genera-
tion were measured. The peak
response of overexpressing cells
was expressed as a percent of
ctrl cells exposed to the same
stimulus. Results shown were
the average of two experiments.
Filled circles, Ca21 signal after
bradykinin stimulation; open cir-
cles, IP3 generated in response
to bradykinin; triangles, Ca21
signal after NaF treatment.Sun et al. Gelsolin, CapG, PIP2, Phospholipase C 815
Gelsolin overexpression reduced the NaF response, sug-
gesting that it acted at or downstream of the heterotri-
meric G protein activation step (Fig. 3 A). However, gelso-
lin did not inhibit the NaF response to as great an extent as
the bradykinin response (Fig. 3 B). The Ca21 peak for C4
was reduced to 1.8 and 47.8% of ctrl after bradykinin and
NaF stimulation, respectively. The difference may be due
to activation of different PLCs. NaF activates all heterotri-
meric G proteins, while bradykinin activates the alpha
subunit (Gaq/11) (11, 29). This was confirmed with pertus-
sis toxin that inhibits Gi but not Gaq/11. In ctrl cells, pertus-
sis toxin reduced the NaF response by 45.7% but had min-
imal effect on the bradykinin response (data not shown).
Our result suggested that Gaq/11-activated PLCs were more
sensitive to gelsolin inhibition than Gai-activated enzymes.
Addition of Exogenous Gelsolin to Streptolysin
O–permeabilized Ctrl Cells 
To determine if the change in PLCb activity is directly at-
tributable to gelsolin, a gelsolin NH2-terminal half polypep-
tide (45 kD, spanning gelsolin residues 1–406 [GS1-406])
that contains at least two PIP2-binding sites (17, 35) was
added to SLO-permeabilized ctrl cells. Under the perme-
abilizing conditions used, cells retained agonist responsive-
ness, as demonstrated previously for another type of cell
(21). Fig. 4 showed the result of a representative experi-
ment. The mean IP3 response in the presence of 4 and 32
mM GS1-406 were 46.5 6 4.0% (n 5 8) and 6.4 6 1.1%
(n 5 3) of control, respectively. Thus, exogenous gelsolin
added to permeabilized cells mimicked the inhibitory ef-
fects of gelsolin overexpression.
Exogenous CapG also inhibited IP3 rise, while thymosin
b4, an actin-binding protein that does not interact with
PIP2 (38), had no effect at 10 mM. (IP3 response was 91.7
and 101.8% of control after bradykinin stimulation in two
experiments.) These results suggested that inhibition of
IP3 generation in cells was linked to an increase in PIP2-
binding proteins.
Regeneration of Bradykinin Response after Cytosol 
Leakage from Semiintact Cells
Our data showed that gelsolin, either overexpressed in in-
tact cells or added to semiintact cells, reduced bradykinin
responsiveness. Removal of gelsolin should restore the
bradykinin response. Cells were permeabilized for pro-
gressively longer intervals before bradykinin stimulation
to allow gelsolin and other cytosolic proteins to leak out.
After 3 min, gelsolin and actin were detected in the me-
dium (Fig. 5 A). More proteins leaked out with longer
treatment. In contrast, PLCb3, the predominant PLC in
NIH3T3 cells, did not leak out to a significant extent, as
would be consistent with its stable plasma membrane asso-
ciation. There was no difference in the leakage of PLCb3
between ctrl and C5.
The effect of cytosol leakage on IP3 generation was de-
termined by stimulating cells permeabilized for different
intervals with bradykinin (Fig. 5 B). Both intact and per-
meabilized ctrl cells increased IP3 after bradykinin stimu-
lation. The semiintact cell’s response was more robust,
suggesting that soluble inhibitors had leaked out or that
other clamping mechanisms were disrupted. As shown
above, intact C5 had a much lower IP3 response than ctrl
cells. At 2 min after SLO treatment, C5 was still inhibited
relative to ctrl. Between 2 to 5 min, C5 response increased
to a level comparable to that of ctrl. With longer perme-
abilization, both ctrl and C5 were less active, probably due
to loss of membrane integrity and depletion of soluble co-
factors such as GTP. The convergence of the IP3 response
between ctrl and C5 was not due to differential leakout of
PLCb3 (Fig. 5 A). Recovery of bradykinin-stimulated PLC
activity indicates that reduced bradykinin responsiveness
in intact overexpressing cells is unlikely to be due to
bradykinin receptor defects. A similar conclusion was
reached using NaF to stimulate G proteins directly (Fig. 3
A). Therefore, we conclude that gelsolin depresses PLC
activity in intact C5, and reducing gelsolin concentration
relieves the inhibition.
Effects of Gelsolin on Phospholipase C In Vitro
It has been reported that gelsolin inhibits several PLC
isozymes in vitro (1). In light of our in vivo results, we re-
examined this issue to determine if gelsolin and CapG in-
hibit PLCb and PLCg differentially, and whether inhibition
is due to PIP2 binding. Gelsolin GS1-406 that contains two
identified PIP2-binding sites increased Ca21-activated PLCb
at 1 mM and inhibited at higher concentrations (Fig. 6 A).
A biphasic effect has been reported previously (1), al-
though the stimulatory phase was ignored. CapG stimu-
lated and inhibited with a comparable dose response, con-
sistent with its similar affinity as gelsolin for PIP2 (18).
Gelsolin also had a biphasic effect on PLCg phosphory-
lated with EGF receptor kinase. In contrast, gelsolin did
Figure 4. Effects of exogenous gelsolin on the IP3 response of
permeabilized ctrl cells. Ctrl cells were permeabilized with SLO
for 4 min, incubated with gelsolin GS1-406 for 3 min, and stimu-
lated with 10 mM bradykinin for 7 s. IP3 release was assayed.
Data shown were from a representative experiment, and each
point was performed in triplicate.The Journal of Cell Biology, Volume 138, 1997 816
not increase the activity of nonphosphorylated PLCg (Fig.
6 B) and inhibited it more strongly. The differential effects
on phosphorylated and unphosphorylated PLCg, including
activation of the phosphorylated enzyme at low concentra-
tion, were similar to that reported previously for profilin
(10). A direct comparison between gelsolin and profilin
showed that gelsolin was a stronger inhibitor (data not
shown), consistent with their different affinity for PIP2 (18,
20). Although gelsolin was reported to bind PLCg (1), we
were not able to detect such an interaction either with pu-
rified proteins or in cell lysates (data not shown). There-
fore, gelsolin is not likely to act by binding PLC directly. 
Gelsolin inhibited Ca21-activated PLCb more than phos-
phorylated PLCg. 2 mM gelsolin stimulated phosphory-
lated PLCg but was located on the inhibitory arm of the
PLCb dose-response curve (Fig. 6, A and B). Stimulation
of phosphorylated PLCg may contribute to the increased
PDGF response in clones overexpressing low levels of
CapG and in the single low-level gelsolin-overexpressing
clone (C3). The higher sensitivity of PLCb to inhibition
may explain why PLCb and PLCg were affected in oppo-
site directions in CapG clones and why the gelsolin clones
showed more inhibition of PLCb than PLCg. Thus, the dif-
ferential inhibitory effects of gelsolin on PLCb and PLCg
in vitro recapitulated the in vivo effects of overexpression.
The inhibitory effect of GS1-406 was overcome by in-
creasing PIP2 concentration. As expected, PLCb generated
more IP3 as the substrate concentration increased. 5 mM
GS1-406 completely inhibited PLCb activity at 5 and 10
mM PIP2 but was progressively less effective at higher PIP2
concentration (Fig. 6 C). No inhibition was observed at
PIP2 concentrations above 120 mM. The simplest interpre-
tation was that gelsolin inhibited PLCb by substrate com-
petition, as suggested for PLCg in an earlier study (1).
Experiments using gelsolin domains with and without
PIP2-binding sites confirmed that gelsolin altered PLC ac-
tivity through PIP2 binding. GS1-406, encompassing gelso-
lin segments 1–3, contains at least two (and possibly three)
PIP2-binding sites (Fig. 7 A). The S1 and S2 PIP2-binding
sites have been mapped precisely by deletion analyses (37)
and peptide analog studies (16, 37). The existence of a
third site is inferred from previous experiments after de-
leting the S2 site and is predicted to be in S3 (37). GS1-
406, which binds PIP2 with an estimated Kd of 2.9 mM and
a stoichiometry of z3 (18), had the most activating and in-
hibitory effects (Fig. 7 B). GS150-406 (S2-3), which binds
with a similar Kd but with a stoichiometry of z2, was slightly
less effective. GS150-267 that contains a single PIP2-binding
site was markedly less effective, while GS171-267 with no
PIP2-binding site had no effect. These results showed that
gelsolin altered PLC activity through PIP2 binding, and
maximal effect was observed with the participation of two
to three PIP2-binding sites. Binding to multiple PIP2 may
form a more stable complex that is less likely to be displaced
by PLC, and the larger polypeptides are likely to be more
effective in sterically hindering PLC access to its substrate.
Figure 5. Restoration of bradykinin response to gelsolin-overexpressing cells after SLO permeabilization. (A) Time course of leakage
of cytosolic proteins. Ctrl cells in suspension were permeabilized at 378C with SLO and centrifuged for 1 min at room temperature. Pel-
lets and supernatants were electrophoresed on SDS–polyacrylamide gels and blotted with anti–mouse gelsolin, antiactin, or anti-PLCb3.
(B). IP3 generation after bradykinin stimulation. Ctrl cells and C5 were exposed to SLO for the amount of time indicated and then stim-
ulated with bradykinin. The C5 Ca21 peak was expressed as a percent of ctrl under identical conditions. Data shown were the means of
two separate experiments.Sun et al. Gelsolin, CapG, PIP2, Phospholipase C 817
P2, the PIP2-binding peptide derived from gelsolin S2
(16), had no effect at low concentration and stimulated
PLCb by more than threefold at 53 mM (Fig.7 C). We were
not able to use more P2 to determine if higher concentra-
tions were inhibitory. P2 may stimulate by organizing PIP2
in a more favorable conformation for PLC hydrolysis. It
may be more stimulatory than the parent S2 domain be-
cause its positive effects are not neutralized by steric hin-
drance to block PLC access. However, in contrast to the
marked stimulation in vitro, P2 had minimal effect on
PLCb activity in permeabilized cells. Semiintact cells treated
with 100 mM P2 showed 72.5 6 6.7% (n 5 9) of the brady-
kinin-induced IP3 response of untreated cells. No stimula-
tion was observed between 5–100 mM (data not shown).
We cannot explain why P2 had divergent effects in vitro
and in vivo.
Discussion
In this paper, we examined the ability of gelsolin and
CapG to compete with PLC for PIP2 in live cells, in semi-
intact cells, and in vitro. The various approaches help to
define the mechanism by which gelsolin and CapG modu-
late PLC activity in two independent signaling pathways.
Our results suggest that these cytoskeletal proteins may
participate in signaling by controlling the availability of
PIP2 substrates.
The CapG and gelsolin overexpressing cell lines were
isolated independently by two different laboratories, using
the same parent NIH3T3 cell line and expression vector.
Their remarkably similar effects on PLCb strongly support
the conclusion that gelsolin and CapG bind PIP2 in vivo to
inhibit PLCb. There are, however, differences with respect
Figure 6. Effect of gelsolin
on PLC activity in vitro. (A)
PLCb1 was activated with 11
mM Ca21, and IP3 release
from PIP2/PE/PS vesicles af-
ter 1 min was determined.
The specific activity was 5.48
mmol/mg/min. Enzyme activ-
ity without added gelsolin
was expressed as 100%, after
background subtraction.
(Background was less than
10% without added Ca21.)
(B) PLCg with and without
EGF receptor (EGFR) ty-
rosine kinase activation. PLC
was incubated with EGF re-
ceptor kinase in the presence
and absence of ATP and
EGF. The activity of the
phosphorylated and unphos-
phorylated enzymes were as-
sayed in the presence of in-
creasing amounts of gelsolin.
IP3 release from PIP2/PE/PS
vesicles after 4 min was ex-
pressed as percent of control
(in the absence of gelsolin).
The specific activity after
background subtraction was
3.74 mmol/mg/min. (C) Ef-
fect of increasing PIP2 mi-
celle concentration on the
ability of gelsolin to inhibit
PLCb. IP3 released into the
supernatant after 15 min was
plotted as a function of PIP2
concentration.The Journal of Cell Biology, Volume 138, 1997 818
to PLCg. At an apparently similar level of overexpression,
CapG clone gK8 and gelsolin clone C6 had increased and
decreased response to PDGF, respectively. The divergent
effects of gelsolin and CapG may be due to multiple fac-
tors. CapG has one PIP2-binding site, while gelsolin has
two (37). CapG is half the size of gelsolin (36). Thus,
CapG may be more readily displaced by activated PLCg
and may not sterically block PLCg access to PIP2 as effec-
tively. CapG is phosphorylated (23), and phospho-CapG
may have a different affinity for PIP2 (Lu, P., A. Hsu, D.
Wong, H. Yan, H.L. Yin, and C. Chen, manuscript submit-
ted for publication). Another possibility may be different
intracellular localization. CapG is a nuclear and cytosolic
protein, while gelsolin is excluded from the nucleus (24).
There is emerging evidence for phosphoinositide signaling
pathways in nuclei (Lu, P., A. Hsu, D. Wong, H. Yan, H.L.
Yin, and C. Chen, manuscript submitted for publication),
and CapG may therefore act in the nucleus.
Another feature that emerges from these studies is that
there is a difference in the sensitivity of PLCb and PLCg
towards gelsolin and CapG. This may be explained in sev-
eral ways. Phosphorylated PLCg may have a higher affin-
ity for PIP2 than PLCb and is therefore better able to com-
pete with gelsolin for PIP2. Differential sensitivity may
account for the paradoxical finding that CapG-overex-
pressing cells have increased PLCg (31) but reduced PLCb
activity. Another possibility is that PLC isozymes may use
different pools of PIP2, and gelsolin/CapG have differen-
tial access to these pools. PIP2 pools with distinct turnover
characteristics have been identified (25), although their re-
Figure 7. Gelsolin-modulated PLCb1 activity through PIP2 bind-
ing. (A) Gelsolin NH2-terminal domains (GS1-406) containing
none or between one to three PIP2-binding sites. Gelsolin seg-
ments 1, 2 and 3 are as defined in reference 17. *PIP2-binding
sites that have been localized. ?, suspected PIP2-binding site that
has not yet been located precisely. (B) Effects of gelsolin do-
mains on PLCb1. (C) Effect of P2 on PLCb1. In B and C, enzyme
activity was assayed for 1 min and expressed as percent of control
in the absence of exogenous protein.Sun et al. Gelsolin, CapG, PIP2, Phospholipase C 819
lation to the different PLC isozymes, gelsolin and CapG,
has not been examined.
Inhibition of PLC is most likely due to competition of
gelsolin and CapG with PLC for PIP2. Steric hindrance
may also be a contributing factor. The mechanism by
which PLC is enhanced by a small increase in CapG or
gelsolin is not known. Since only gelsolin domains with
PIP2-binding sites stimulate, this effect depends on PIP2
binding. The simplest hypothesis is that gelsolin and CapG
improve the presentation of PIP2 to PLC by altering the
phospholipid conformation. Among the gelsolin domains
tested, P2, the small synthetic peptide containing a single
PIP2-binding site, is most stimulatory in vitro. However, it
does not have any effect on PLC in semiintact cells. This
peptide has been used by others to examine the relation
between gelsolin and PIP2 in cells (8, 13). P2 added to
semiintact platelets blocks Rac1-induced uncapping of ac-
tin filament 1 ends, and this effect is overcome by adding
PIP2 (13). Overexpression of P2 in a permanently trans-
fected cell line reduces gelsolin association with the
plasma membrane (8). Both experiments indicate that P2
competes with gelsolin for PIP2, although effects on other
PIP2 -requiring processes have not been ruled out. Our re-
sult suggests that PLC was not affected by increasing P2
levels in cells. Additional experiments will be required to
determine if other parameters are altered by P2.
In conclusion, we show that gelsolin and CapG interact
with PIP2 in vivo, and a modest increase in concentration
has profound effects on two PIP2 signaling pathways.
Overexpression is used as a tool to probe intracellular
function. Our overexpression results have physiological
relevance. While total gelsolin and CapG content do not
change per se, cytosolic concentration and membrane
binding are expected to fluctuate during signaling. Gelso-
lin and CapG bind to and are released from filament ends
and the membrane PIP2 content changes due to hydrolysis
and resynthesis. Ca21 increases gelsolin and CapG affinity
for PIP2 (18), enhancing their ability to compete with
other PIP2-binding proteins at a time when membrane
PIP2 content decreases. CapG and gelsolin can provide
positive and negative inputs on PLC signaling pathways,
and these pathways are modulated selectively. The data
presented here indicate that there is significant cross talk
between components of the transmembrane signal ma-
chinery and actin cytoskeleton at multiple levels, including
that of the generation of important second messengers.
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